Skip to content

Haemonetics HAE Total Operating Expenses

Total Operating Expenses at other companies

Boston Scientific logo
Boston ScientificBSX
$2.51B+9.8%
ICU Medical logo
ICU MedicalICUI
$192.65M-2.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$140.64M+7.4%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1.46B+5.7%
TEC
Bio-TechneTECH
$132.79M-24.5%
Stryker logo
StrykerSYK
$2.87B-1.1%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's total operating expenses?
Haemonetics (HAE) reported total operating expenses of $221.24M in Q1 2026.
How has Haemonetics's total operating expenses changed year-over-year?
Haemonetics's total operating expenses increased by 81.8% year-over-year, from $121.72M to $221.24M.
What is the long-term trend for Haemonetics's total operating expenses?
Over 4 years (2022 to 2026), Haemonetics's total operating expenses has grown at a 10.4% compound annual growth rate (CAGR), from $424.75M to $630.85M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.